Pramipexole Dihydrochloride Tablet, Extended Release
Product Images NDC 55111-613

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pramipexole Dihydrochloride (NDC 55111-613). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1

Container1
This is a prescription drug named Pramipexole Dihydrochloride Extended-release, which comes in the form of tablets with a strength of 0.375mg. It is meant to be taken once daily swallowed whole and not chewed, crushed, or divided. Dr.Reddy's Laboratories distributes the drug in the United States. This drug should be kept in a controlled temperature environment and out of reach of children. However, there is no information on what this medicine is for.*
FDA Label Image

Container2

Container2
This is a medication called Pramipexole Dihydrochloride Monohydrate. It comes in extended-release tablets of 0.75mg and should be taken once daily. The tablets should not be chewed, crushed or divided. It must be stored in a controlled room temperature and protected from high humidity. The medicine should be kept out of reach of children. The medication comes in a container with 30 tablets which should be dispensed in the original container. The manufacturer of the medication is Reddy's Laboratories, located in Princeton.*
FDA Label Image

Container3

Container3
This is a medication with the name Pramipexole Dihydrochloride. It comes in extended release tablets with the strength of 1.5 mg. The recommended dosage should be taken as per the accompanying prescription information. The tablets should be swallowed whole and not to be crushed, chewed, or divided. The medication should be stored in a cool and dry place at room temperature between 20-25 degrees Celsius. The medicine comes in a Unit of Use Container with 30 tablets from Dr. Reddy's Laboratories. The medication is intended for use only with a doctor's prescription. The label area for the medicine has a size of 35x40mm.*
FDA Label Image

Container4

Container4
This is a medication description for Pramipexole Dihydrochloride Extended-Release Tablets, 3 mg. It advises to take one tablet daily and not to crush or divide the tablet. It recommends storing at room temperature and protecting from excessive light and humidity. The medication is distributed by Dr. Reddy's Laboratories in the USA and manufactured in India.*
FDA Label Image

Container5

Container5
Each tablet contains 45mg of Pramipexole dihydrochloride monohydrate equivalent to 0.423mg Pramipexole. It is a prescription drug that should be taken once daily. The usual dosage must be read with the accompanying prescribing information. The extended-release tablets should be swallowed whole and must not be chewed, crushed or divided. It should be stored at a controlled temperature between 20-25°C (68-77°F) and protected from exposure to high humidity. The product should be dispensed in the original unit of use container. The manufacturer of the product is Dr. Reddy's Laboratories, Inc., located in Princeton, NJ 08540, USA, and the NDC for this product is 55045-615-30. The text appears to be a product label or insert.*
FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.